Skip to content
Screener

Strata Critical Medical SRTA Q1 2026 earnings

Reported May 6, 2026 · Before market open

Revenue$67.4MBeat by $3.7M
EPS$0.03Beat by $0.07
Revenue estimate$63.7M
EPS estimate-$0.04

Next report

Nov 9, 2026 (In 3 weeks)
Revenue estimate$72.7M
EPS estimate$0.01

Financials

Q1 2026

Income statement

See full
Revenue$67.4M+87.4%
Gross profit$14.1M+100%
Operating income-$3.0M+47.7%
Net income$2.2M+162%
EPS (diluted)$0.03+175%

Balance sheet

See full
Cash & equivalents$59.0M+65.3%
Total debt$4.5M-50.7%
Total equity$285.7M+30.0%
Total assets$327.6M+30.8%

Cash flow

See full
Operating cash flow$3.9M+1,679%
CapEx$5.2M+98.1%
Free cash flow-$1.3M+54.8%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$363.61M—
Enterprise value$309.1M—
P/S1.4×—

Profitability

See full
Gross margin21.7%+1.3pp
Operating margin-7.8%-2.8pp
FCF margin-22.4%+1,712pp

Returns & leverage

See full
Debt / equity0×0.0×
Current ratio5.9×-1.0×

Segments

By segment

See full
Logistics$47.6M—
Clinical$19.8M—

By product

See full
Other Clinical$9.9M—
Transplant Clinical$9.8M—

FAQ

When did Strata Critical Medical report Q1 2026 earnings?
Strata Critical Medical (SRTA) reported Q1 2026 earnings on May 6, 2026 before market open.
What were Strata Critical Medical's Q1 2026 revenue and EPS?
Strata Critical Medical reported revenue of $67.4M and eps of $0.03 for Q1 2026.
Did Strata Critical Medical beat estimates in Q1 2026?
Revenue beat the consensus estimate of $63.7M by $3.7M. EPS beat the consensus estimate of $-0.04 by $0.07.
How did Strata Critical Medical's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 24.1% from $54.3M a year earlier.
Where can I find Strata Critical Medical's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-030898) and the 10-Q periodic report (0001628280-26-031032) directly on SEC EDGAR. The filing index links above go to sec.gov.